Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 111,793,608
  • Shares Outstanding, K 110,186
  • Annual Sales, $ 13,117 M
  • Annual Income, $ 3,954 M
  • 60-Month Beta 0.12
  • Price/Sales 8.74
  • Price/Cash Flow 24.30
  • Price/Book 4.11
Trade REGN with:

Options Overview Details

View History
  • Implied Volatility 33.56% ( +1.66%)
  • Historical Volatility 23.80%
  • IV Percentile 98%
  • IV Rank 90.64%
  • IV High 35.23% on 07/30/24
  • IV Low 17.43% on 06/12/24
  • Put/Call Vol Ratio 2.83
  • Today's Volume 2,151
  • Volume Avg (30-Day) 1,475
  • Put/Call OI Ratio 1.21
  • Today's Open Interest 38,410
  • Open Int (30-Day) 34,432

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 10.04
  • Number of Estimates 9
  • High Estimate 11.27
  • Low Estimate 9.28
  • Prior Year 10.17
  • Growth Rate Est. (year over year) -1.28%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1,008.41 +0.61%
on 09/25/24
1,182.31 -14.19%
on 09/04/24
-154.22 (-13.19%)
since 09/03/24
3-Month
1,008.41 +0.61%
on 09/25/24
1,211.20 -16.23%
on 08/27/24
-9.50 (-0.93%)
since 07/03/24
52-Week
769.19 +31.90%
on 10/27/23
1,211.20 -16.23%
on 08/27/24
+206.28 (+25.52%)
since 10/03/23

Most Recent Stories

More News
Here's Why You Should Add ALNY Stock to Your Portfolio Right Now

Alnylam Pharmaceuticals ALNY focuses on developing novel therapeutics based on RNAi technology. The company’s pipeline of experimental RNAi therapeutics is focused on three strategic therapeutic areas...

ALNY : 269.53 (-0.74%)
NVS : 113.77 (-0.61%)
REGN : 1,014.59 (-2.47%)
RHHBY : 38.2800 (-2.02%)
Sanofi, Regeneron's Dupixent Gets FDA Approval for COPD

Sanofi SNY and partner Regeneron REGN announced that the FDA has approved their blockbuster drug, Dupixent, for its sixth indication — chronic obstructive pulmonary disease (COPD) — in the United States....

LLY : 885.55 (-0.62%)
REGN : 1,014.59 (-2.47%)
PFE : 28.34 (-0.94%)
SNY : 55.54 (-1.26%)
Bayer Submits Application for Label Expansion of Prostate Cancer Drug

Bayer BAYRY announced the submission of a supplemental new drug application (sNDA) to the FDA for darolutamide.The sNDA is seeking approval of darolutamide, in combination with androgen deprivation therapy...

BAYRY : 8.2500 (-1.67%)
LLY : 885.55 (-0.62%)
REGN : 1,014.59 (-2.47%)
PFE : 28.34 (-0.94%)
AMGN Stock Falls Despite Upbeat Data on Immunology Drugs: Here's Why

Shares of Amgen AMGN fell by more than 5% on Wednesday after it reported top-line data on two different drugs in the autoimmune disease space. While the studies did meet their respective primary endpoints,...

REGN : 1,014.59 (-2.47%)
ARGX : 542.99 (-1.27%)
AMGN : 317.48 (-0.70%)
SNY : 55.54 (-1.26%)
Stocks Settle Higher as Chinese Stimulus Boosts Economic Growth Prospects

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up by +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +0.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up by +0.47%. Stocks on...

AMAT : 199.59 (-0.78%)
AVGO : 171.89 (+0.72%)
GPN : 98.19 (+0.54%)
$IUXX : 19,793.34 (-0.05%)
ASML : 832.41 (+0.03%)
ZNZ24 : 113-275 (-0.04%)
NTES : 101.46 (-2.69%)
PDD : 152.62 (-0.06%)
V : 276.86 (-0.05%)
LRCX : 81.11 (-0.37%)
$DOWI : 42,011.59 (-0.44%)
SCCO : 115.32 (-1.71%)
Regeneron Stock Down on Court Ruling for Amgen's Biosimilar of Eylea

Shares of Regeneron Pharmaceuticals, Inc. REGN were down 4.63% after an unfavorable ruling in its lawsuit against Amgen AMGN in the United States District Court for the Northern District of West Virginia.The...

BAYRY : 8.2500 (-1.67%)
REGN : 1,014.59 (-2.47%)
RHHBY : 38.2800 (-2.02%)
AMGN : 317.48 (-0.70%)
Stocks Slightly Higher as Chinese Stimulus Boosts Risk Sentiment in Asset Markets

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.04%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.30%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.12%. Stocks today are slightly...

$IUXX : 19,793.34 (-0.05%)
ZNZ24 : 113-275 (-0.04%)
NTES : 101.46 (-2.69%)
PDD : 152.62 (-0.06%)
V : 276.86 (-0.05%)
$DOWI : 42,011.59 (-0.44%)
SCCO : 115.32 (-1.71%)
YUMC : 49.24 (-3.47%)
SPY : 567.82 (-0.18%)
DIA : 419.98 (-0.46%)
UBER : 72.94 (+0.10%)
BABA : 112.84 (-2.09%)
Stocks Climb as Chinese Stimulus Measures Boost Risk Sentiment

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.12%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.17%. Stocks today are moderately...

AMAT : 199.59 (-0.78%)
ADI : 226.56 (-0.51%)
TXN : 201.67 (-0.87%)
$IUXX : 19,793.34 (-0.05%)
ZNZ24 : 113-275 (-0.04%)
NTES : 101.46 (-2.69%)
PDD : 152.62 (-0.06%)
SBUX : 95.56 (-0.97%)
QCOM : 168.92 (+0.36%)
V : 276.86 (-0.05%)
LRCX : 81.11 (-0.37%)
$DOWI : 42,011.59 (-0.44%)
Optimism Grows in the Fight Against Cancer as Breakthroughs and Funding Increase

/CNW/ -- USA News Group – Optimism is on the rise in fight against cancer, as researchers are making progress across the field of oncology. Helping to spur on...

ONCY : 0.9305 (+9.09%)
FHTX : 7.48 (-10.20%)
NRIX : 21.67 (-1.37%)
INCY : 67.04 (-0.87%)
ONC.TO : 1.27 (+5.83%)
REGN : 1,014.59 (-2.47%)
Stock Index Futures Climb as China Stimulus Buoys Global Risk Appetite

December S&P 500 E-Mini futures (ESZ24) are up +0.21%, and December Nasdaq 100 E-Mini futures (NQZ24) are up +0.30% this morning as global risk sentiment got a boost after Beijing announced one of its...

SMIN.LN : 1,651.000 (-0.72%)
TSLA : 240.66 (-3.36%)
SBUX : 95.56 (-0.97%)
INTC : 22.26 (-0.58%)
V : 276.86 (-0.05%)
NQZ24 : 20,049.75 (+0.30%)
REGN : 1,014.59 (-2.47%)
ESZ24 : 5,760.75 (+0.20%)
UBER : 72.94 (+0.10%)
HE : 9.77 (+5.62%)
WMT : 80.43 (unch)
CRM : 280.91 (+0.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Regeneron is a biotechnology company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. The company's portfolio boasts nine marketed drugs - Eylea, Dupixent, Praluent, Kevzara, Libtayo, Evkeeza, Inmazeb Arcalyst and Zaltrap. The company also...

See More

Key Turning Points

3rd Resistance Point 1,059.26
2nd Resistance Point 1,049.04
1st Resistance Point 1,031.81
Last Price 1,014.59
1st Support Level 1,004.36
2nd Support Level 994.14
3rd Support Level 976.91

See More

52-Week High 1,211.20
Fibonacci 61.8% 1,042.35
Last Price 1,014.59
Fibonacci 50% 990.19
Fibonacci 38.2% 938.04
52-Week Low 769.19

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar